Published in Semin Dial on September 14, 2006
Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One (2014) 1.51
Pulmonary hypertension in dialysis patients: a cross-sectional italian study. Int J Nephrol (2010) 1.04
Pulmonary Hypertension and Right Heart Failure in Chronic Kidney Disease: New Challenge for 21st-Century Cardionephrologists. Cardiorenal Med (2013) 0.85
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
Renal transplant improves pulmonary hypertension in patients with end stage renal disease. Multidiscip Respir Med (2011) 0.78
Kidney pulmonary hypertension: another road on the map? Multidiscip Respir Med (2011) 0.77
Frequency of pulmonary hypertension in hemodialysis patients. Pak J Med Sci (2015) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease. Adv Biomed Res (2015) 0.75
The Effect of Haemodialysis Access Types on Cardiac Performance and Morbidities in Patients with Symptomatic Heart Disease. PLoS One (2016) 0.75
Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients. J Diabetes Res (2015) 0.75
Pulmonary hypertension: prevalence and risk factors. Int J Cardiol Heart Vasc (2016) 0.75
Pulmonary hypertension in patients with end-stage renal disease. Chest (2003) 1.89
Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res (2005) 1.70
Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med (2003) 1.68
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes (2008) 1.64
The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant (2005) 1.62
Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail (2013) 1.60
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes (2005) 1.53
Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int (2009) 1.51
Unexplained severe pulmonary hypertension in the elderly: report on 14 patients. Isr Med Assoc J (2004) 1.41
A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int (2003) 1.31
Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest (2008) 1.12
Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res (2005) 1.07
Double gene deletion reveals lack of cooperation between claudin 11 and claudin 14 tight junction proteins. Cell Tissue Res (2008) 1.07
Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens (2006) 1.05
An ELISA method for the detection and quantification of human heparanase. Biochem Biophys Res Commun (2006) 1.03
Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels. PLoS One (2011) 1.01
Pathophysiology and clinical implications of microbubbles during hemodialysis. Semin Dial (2008) 0.99
Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr (2007) 0.99
Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol (2006) 0.97
Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res (2010) 0.94
Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J (2009) 0.94
The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res (2005) 0.93
Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation (2002) 0.93
Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc (2008) 0.93
Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol (2011) 0.92
Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery. Ann Emerg Med (2002) 0.92
Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse. J Invest Surg (2005) 0.90
Pulmonary calcification in hemodialysis patients: correlation with pulmonary artery pressure values. Kidney Int (2004) 0.89
Large pseudoaneurysms of the mitral-aortic intervalvular fibrosa: long-term natural history without surgery in two patients. Eur J Echocardiogr (2011) 0.89
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res Cardiol (2010) 0.89
An academic medical center under prolonged rocket attack--organizational, medical, and financial considerations. Acad Med (2009) 0.88
A rare bacteremia caused by Cedecea davisae in patient with chronic renal disease. Am J Case Rep (2013) 0.88
Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant (2008) 0.86
Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem (2004) 0.86
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol (2013) 0.85
Comparison of multidetector computed tomography versus echocardiography for assessing regional left ventricular function. Am J Cardiol (2005) 0.85
Frequency, determinants and outcome of pulmonary hypertension in patients with aortic valve stenosis. Am J Med Sci (2012) 0.83
Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction. Diabetes Care (2003) 0.83
Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol Renal Physiol (2007) 0.83
Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One (2013) 0.83
Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano (2009) 0.83
Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sci (2012) 0.83
Arterio-venous access in end-stage renal disease patients and pulmonary hypertension. Ther Adv Respir Dis (2008) 0.83
Evaluation of inotropic changes in ventricular function by NOGA mapping: comparison with echocardiography. J Appl Physiol (1985) (2002) 0.82
Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Circ Heart Fail (2011) 0.82
Effects of diabetes mellitus, chronic renal failure and hemodialysis on serum and salivary antioxidant status. Nephron Clin Pract (2006) 0.81
Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol (2004) 0.81
Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev (2007) 0.81
Corin: a new player in the regulation of salt-water balance and blood pressure. Curr Opin Nephrol Hypertens (2013) 0.81
Incidence and risk factors for endocarditis among patients with health care-associated Staphylococcus aureus bacteraemia. Scand J Infect Dis (2012) 0.81
Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond) (2012) 0.81
Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury. Am J Physiol Renal Physiol (2013) 0.80
Inhibition of diabetic nephropathy in rats by an oral antidiabetic material extracted from yeast. J Am Soc Nephrol (2006) 0.80
Renal slit diaphragm--the open zipper and the failing heart. Isr Med Assoc J (2007) 0.80
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol (2005) 0.80
Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev (2005) 0.80
Kidney-ear axis. Isr Med Assoc J (2007) 0.80
Pneumoperitoneum aggravates renal function in cases of decompensated but not compensated experimental congestive heart failure: role of nitric oxide. J Urol (2011) 0.79
Vogt-Koyanagi-Harada syndrome associated with renal failure: a case report. J Nephrol (2006) 0.79
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J Pharmacol Exp Ther (2010) 0.79
[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Harefuah (2008) 0.79
Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
Hyponatraemia predicts the acute (type 1) cardio-renal syndrome. Eur J Heart Fail (2013) 0.79
Role of haptoglobin phenotype in end-stage kidney disease. Nephron Exp Nephrol (2004) 0.79
Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology (2008) 0.79
Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrol Dial Transplant (2006) 0.78
Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure. Surg Endosc (2009) 0.78
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. Atherosclerosis (2012) 0.78
Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome. Nephrol Dial Transplant (2011) 0.78
TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs. J Cardiovasc Pharmacol (2015) 0.78
Patterns of alveolar fluid clearance in heart failure. Int J Cardiol (2008) 0.78
Karyomegalic Interstitial Nephritis with Chronic Kidney Disease. Isr Med Assoc J (2015) 0.77
Failure of left ventricular hypertrophy to regress after surgery for aortic valve stenosis. Echocardiography (2002) 0.77
Role of neuropeptide Y in the regulation of kidney function. EXS (2006) 0.77
Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure. Eur J Heart Fail (2012) 0.76
Left ventricular filling hemodynamics in patients with pulmonary edema and preserved versus reduced left ventricular ejection fraction: a prospective Doppler echocardiographic study. J Am Soc Echocardiogr (2006) 0.76
Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma. World J Urol (2013) 0.76
Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model. Am J Respir Cell Mol Biol (2012) 0.76
Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol Lung Cell Mol Physiol (2006) 0.76
Excessive respiratory variation in tricuspid regurgitation systolic velocities in patients with severe tricuspid regurgitation. Eur Heart J Cardiovasc Imaging (2013) 0.76
Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide. Surg Endosc (2013) 0.76
Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol (2004) 0.75
Correction: The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport. PLoS One (2015) 0.75
Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol (2010) 0.75
Herpes simplex viral infection presenting as fever of unknown origin and esophagitis in a renal transplant patient. Isr Med Assoc J (2002) 0.75
Hyponatremia as a complication of cardiac catheterization: a prospective study. Am J Kidney Dis (2002) 0.75
Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model. J Pediatr Gastroenterol Nutr (2009) 0.75
[Aldosterone--classic and non classic effects]. Harefuah (2002) 0.75
Urinary excretion of endothelin receptors ET A and ET B in hypertensive patients and normotensive subjects. Kidney Blood Press Res (2009) 0.75
Renal and systemic effects of endothelin-1 in diabetic-hypertensive rats. Clin Exp Hypertens (2011) 0.75